The Scientific Library recently hosted a discussion panel on electron microscopy services at the National Cancer Institute (NCI) at Frederick and Frederick National Laboratory for Cancer Research (FNL), its third panel of 2020. This Electron Microscopy Discussion Panel brought together specialists from the Electron Microscopy Laboratory, the Center for Molecular Microscopy, and the National Cryo-Electron Microscopy Facility (NCEF).

The Frederick National Laboratory for Cancer Research, in partnership with NCI and the NIH Clinical Center, recently began asymptomatic COVID-19 testing for government and Leidos Biomedical Research, Inc., staff. This program is voluntary but encouraged for those currently working on-site.

Science is an interrogation of reality: “putting Nature through a thorough inquisition,” as poet W. H. Auden once wrote. It’s the search for what’s real. But sometimes traditional practices get in the way. What to do when reality itself slows the search?

The 2020 Technology Showcase welcomed more than 300 viewers for half a day of presentations and panels on technology commercialization and collaboration. The annual event once again highlighted the capabilities of the Frederick National Laboratory for Cancer Research, National Cancer Institute, and greater Frederick region—but this year, with its novel virtual format, it reached new audiences.

Just a few years ago, it was difficult to get any meaningful sequence data from formalin-fixed, paraffin-embedded patient tissue samples. These biopsy specimens, which are tissues preserved in formaldehyde and embedded in wax for storage, are easy to make and store, even in remote research locations. Many are available, and more are made all the time, for use in experimental research and drug development. Because there are so many samples that have been taken over numerous years, they can also be used to help study the evolution of diseases and viruses.